A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms[S]

High lipoprotein (a) [Lp(a)] concentrations are an independent risk factor for cardiovascular outcomes. Concentrations are strongly influenced by apo(a) kringle IV repeat isoforms. We aimed to identify genetic loci associated with Lp(a) concentrations using data from five genome-wide association studies (n = 13,781). We identified 48 independent SNPs in the LPA and 1 SNP in the APOE gene region to be significantly associated with Lp(a) concentrations. We also adjusted for apo(a) isoforms to identify loci affecting Lp(a) levels independently from them, which resulted in 31 SNPs (30 in the LPA, 1 in the APOE gene region). Seven SNPs showed a genome-wide significant association with coronary artery disease (CAD) risk. A rare SNP (rs186696265; MAF ∼1%) showed the highest effect on Lp(a) and was also associated with increased risk of CAD (odds ratio = 1.73, P = 3.35 × 10−30). Median Lp(a) values increased from 2.1 to 91.1 mg/dl with increasing number of Lp(a)-increasing alleles. We found the APOE2-determining allele of rs7412 to be significantly associated with Lp(a) concentrations (P = 3.47 × 10−10). Each APOE2 allele decreased Lp(a) by 3.34 mg/dl corresponding to ∼15% of the population’s mean values. Performing a gene-based test of association, including suspected Lp(a) receptors and regulators, resulted in one significant association of the TLR2 gene with Lp(a) (P = 3.4 × 10−4). In summary, we identified a large number of independent SNPs in the LPA gene region, as well as the APOE2 allele, to be significantly associated with Lp(a) concentrations.

[1]  C. Gieger,et al.  A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction , 2017, European heart journal.

[2]  S. Tsimikas,et al.  Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[3]  P. Clopton,et al.  LPA Gene, Ethnicity, and Cardiovascular Events , 2017, Circulation.

[4]  Gonçalo R. Abecasis,et al.  Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels. , 2016, Journal of the American College of Cardiology.

[5]  S. Crooke,et al.  Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials , 2016, The Lancet.

[6]  K. Frazer,et al.  Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins , 2016, Circulation. Cardiovascular genetics.

[7]  F. Kronenberg,et al.  Structure, function, and genetics of lipoprotein (a) , 2016, Journal of Lipid Research.

[8]  J. Cunningham,et al.  Sex‐Specific Genetic Variants are Associated With Coronary Endothelial Dysfunction , 2016, Journal of the American Heart Association.

[9]  Marcelo P. Segura-Lepe,et al.  Meta-analysis of 49 549 individuals imputed with the 1000 Genomes Project reveals an exonic damaging variant in ANGPTL4 determining fasting TG levels , 2016, Journal of Medical Genetics.

[10]  Obi L. Griffith,et al.  ORegAnno 3.0: a community-driven resource for curated regulatory annotation , 2015, Nucleic Acids Res..

[11]  William Valdar,et al.  Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study , 2015, Journal of Human Genetics.

[12]  J. Danesh,et al.  A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease , 2016 .

[13]  Malte Kelm,et al.  Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. , 2015, Annals of internal medicine.

[14]  Sara M. Willems,et al.  The impact of low-frequency and rare variants on lipid levels , 2015, Nature Genetics.

[15]  G. Kempermann.  Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .

[16]  Jun S. Liu,et al.  The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.

[17]  J. O’Connell,et al.  Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. , 2015, Human molecular genetics.

[18]  F. Fresser,et al.  Sequence Variation within the KIV-2 Copy Number Polymorphism of the Human LPA Gene in African, Asian, and European Populations , 2015, PloS one.

[19]  Gabi Kastenmüller,et al.  SNiPA: an interactive, genetic variant-centered annotation browser , 2014, Bioinform..

[20]  D. Gianola,et al.  Genomic Heritability: What Is It? , 2014, PLoS genetics.

[21]  F. Kronenberg.  Genetic determination of lipoprotein(a) and its association with cardiovascular disease: convenient does not always mean better , 2014, Journal of internal medicine.

[22]  M. Phillips.  Apolipoprotein E isoforms and lipoprotein metabolism , 2014, IUBMB life.

[23]  M. Farrall,et al.  A Common LPA Null Allele Associates With Lower Lipoprotein(a) Levels and Coronary Artery Disease Risk , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[24]  P. Hopkins,et al.  Hyperlipoproteinemia Type 3: The Forgotten Phenotype , 2014, Current Atherosclerosis Reports.

[25]  Andres Metspalu,et al.  Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population , 2014, PLoS genetics.

[26]  Q. Lu,et al.  TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review , 2014, Clinical Reviews in Allergy & Immunology.

[27]  F. Kronenberg,et al.  Lipoprotein(a): resurrected by genetics , 2013, Journal of internal medicine.

[28]  F. Hu,et al.  Prevention and epidemiology , 2011 .

[29]  Iris M Heid,et al.  To stratify or not to stratify: power considerations for population‐based genome‐wide association studies of quantitative traits , 2011, Genetic epidemiology.

[30]  M. Okubo,et al.  Lipoprotein(a)-cholesterol: a significant component of serum cholesterol. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[31]  F. Kronenberg,et al.  Meta analysis of candidate gene variants outside the LPA locus with Lp(a) plasma levels in 14,500 participants of six White European cohorts. , 2011, Atherosclerosis.

[32]  Eleazar Eskin,et al.  Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. , 2011, American journal of human genetics.

[33]  Mika Kivimäki,et al.  Conventional and Mendelian randomization analyses suggest no association between lipoprotein(a) and early atherosclerosis: the Young Finns Study. , 2011, International journal of epidemiology.

[34]  Johnny S. H. Kwan,et al.  GATES: a rapid and powerful gene-based association test using extended Simes procedure. , 2011, American journal of human genetics.

[35]  S. Yusuf,et al.  Parental history and myocardial infarction risk across the world: the INTERHEART Study. , 2011, Journal of the American College of Cardiology.

[36]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[37]  P. Sham,et al.  A Knowledge-Based Weighting Framework to Boost the Power of Genome-Wide Association Studies , 2010, PloS one.

[38]  K. Moore,et al.  Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. , 2010, Cell metabolism.

[39]  M. Koschinsky,et al.  The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles. , 2010, Atherosclerosis.

[40]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[41]  S. Yusuf,et al.  Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians , 2010, Circulation. Cardiovascular genetics.

[42]  R. Collins,et al.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.

[43]  Børge G Nordestgaard,et al.  Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. , 2009, JAMA.

[44]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[45]  K. Feingold,et al.  Inflammation stimulates the expression of PCSK9. , 2008, Biochemical and biophysical research communications.

[46]  M. Rieder,et al.  LPA and PLG Sequence Variation and Kringle IV-2 Copy Number in Two Populations , 2008, Human Heredity.

[47]  Mark I. McCarthy,et al.  A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs) , 2008, PLoS genetics.

[48]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[49]  W. Parson,et al.  A common nonsense mutation in the repetitive Kringle IV‐2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a) , 2004, Human mutation.

[50]  S. Humphries,et al.  Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia implication for lipoprotein(a) metabolism , 1994, The clinical investigator.

[51]  G. Utermann,et al.  The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration , 1992, Human Genetics.

[52]  B. Knight,et al.  Sequence and functional changes in a putative enhancer region upstream of the apolipoprotein(a) gene. , 2003, Atherosclerosis.

[53]  C. Ehnholm,et al.  Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. , 2001, Human molecular genetics.

[54]  F. Leus,et al.  The Identification of Polymorphisms in the Coding Region of the Apolipoprotein (a) Gene , 1999, Thrombosis and Haemostasis.

[55]  G. Utermann,et al.  Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians. , 1999, Human molecular genetics.

[56]  F. Acquati,et al.  Characterization of Multiple Enhancer Regions Upstream of the Apolipoprotein(a) Gene* , 1997, The Journal of Biological Chemistry.

[57]  E. Janus,et al.  Frequency Distributions of Apolipoprotein(a) Kringle IV Repeat Alleles and Their Effects on Lipoprotein(a) Levels in Caucasian, Asian, and African Populations: The Distribution of Null Alleles Is Non-Random , 1996, European journal of human genetics : EJHG.

[58]  A. Scanu,et al.  Post-prandial Lp(a): identification of a triglyceride-rich particle containing apo E. , 1994, Chemistry and Physics of Lipids.

[59]  D. Rader,et al.  Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. , 1993, The Journal of clinical investigation.

[60]  E. Boerwinkle,et al.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.

[61]  E. Boerwinkle,et al.  Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. , 1991, The Journal of clinical investigation.

[62]  G. Utermann,et al.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. , 1987, The Journal of clinical investigation.

[63]  G. Utermann,et al.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man , 1977, Nature.